Skip to main content

Table 1 Pharmacokinetic parameters of DOX in control and ADI groups after single intravenous administration of DOX (7 mg/kg) (\( \overline{X} \) ± SD, n = 6)

From: Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma

Parameters

Control

ADI

t1/2α (h)

0.074 ± 0.005

0.089 ± 0.017**

t1/2β (h)

2.734 ± 1.385

2.638 ± 1.108

V1 (L/kg)

0.099 ± 0.026

0.028 ± 0.011**

CL (L/h/kg)

0.37 ± 0.15

0.099 ± 0.048*

AUC0-t (mg/L*h)

20.21 ± 11.22

76.50 ± 34.89**

K10 (1/h)

3.91 ± 1.67

3.68 ± 1.69

K12 (1/h)

5.26 ± 2.05

4.27 ± 0.73

K21 (1/h)

0.77 ± 0.49

0.65 ± 0.48

  1. Data are presented as mean ± SD (n = 6). *P < 0.05, **P < 0.01 versus control group
  2. t½α, half-life of distribution; t½β, half-life of elimination; V1, apparent volume of distribution in central compartment; CL, clearance; AUC0-t, area under plasma drug concentration-time curve; K10, elimination rate constant of drug from compartment 1; K12, rate constant for movement of drug from compartment 1 to compartment 2; K21, rate constant for movement of drug from compartment 2 to compartment 1